Company Search

Education Flash Analysis

SLRX

Other Symbols: FLKS

Salarius Pharmaceuticals, Inc.

NASD, Healthcare, Biotechnology, USA

Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing treatments for cancers with unmet medical need. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds and Cancer Prevention and Research Institute of Texas for product development activities. Salarius Pharmaceuticals, Inc. is headquartered in Houston, Texas.



Market Cap Shares Float Float Held by Institutions % Shares Outstanding Shares Authorized Institutional Own %
10.92 M 14.10 M 6.87% 14.19 M 100.00 M 6.45%
Date of Short Interest by FINRA Shares Sold Short Short Float % Insider Own % Number Institutions Holding Shares MVPHS
31-Aug-2023 0.03 M 0.80% 6.12% 13 $21.86 M

Financial Doc Link Date of Doc Cash Equivalents Burn Rate Operating Activities (monthly) Operating Expenses (monthly) Estimated Months Left of Cash
10-Q 11-May-2023 $9.27 M $1.06 M $1.24 M 3.78
Current Assets Current Liabilities Working Capital Total Assets Total Liabilities Total Revenues (12 mo)
$9.94 M Unavailable Unavailable $10.06 M $4.50 M $0.00 M

Dilutive convertible shares can impact a stock's price by increasing the number of outstanding shares, potentially reducing the value of existing shares and decreasing the stock price.

Sign up to see if this company has convertible shares


Stock Warrants can increase share count when exercised. This dilutions affects earnings per share and potentially reduces stock value and impacting investments.

Sign up to see if this company has dilutive warrants


The liquidity and capital resources provides information on the company's cash position, debt levels, and ability to generate cash, indicating its financial stability and potential for growth.

Sign up to see if this company has a need to raise


Shelf Registrations can impact a stock's price by increasing the supply of shares available for sale, potentially lowering demand and decreasing stock price, leading to decreased returns on investors.

Sign up to see if this company has any shelf registrations


Shelf Registrations can impact a stock's price by increasing the supply of shares available for sale, potentially lowering demand and decreasing stock price, leading to decreased returns on investors.

Sign up to see if this company has any shelf registrations pending effect


Registration Statements, which provide information on a company's financials and business plans before a public offering, can impact trading by affecting investor perception and demand for the stock, potentially leading to price changes.

Sign up to see if this company has any registration statements


Registration Statements, which provide information on a company's financials and business plans before a public offering, can impact trading by affecting investor perception and demand for the stock, potentially leading to price changes.

Sign up to see if this company has any registration statements pending effect


Company current reports can impact investments by providing important information on material events and changes at the company, affecting the stock price and potential for gains or losses.

Sign up to see if this company has any current reports

Changes in a company's share structure, such as issuing new shares, buying back shares, or issuing stock options, can impact stock investments by altering the supply and demand of a company's stock, potentially affecting the stock price and investment return.

Sign up to see if this company has any changes in share structure